Development of mHealth applications for pre-eclampsia triage. IEEE J Biomed Health Inform. 2014;18(6):1857-64.
(300.31 KB)
. 
A core outcome set for pre‐eclampsia research: An international consensus development study. BJOG: An International Journal of Obstetrics & Gynaecology. 2020;.
(257.34 KB)
. 
A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia. Pregnancy Hypertens. 2016;6(4):274-278.
(336.66 KB)
. 
How accurate are modelled birth and pregnancy estimates? Comparison of four models using high resolution maternal health census data in southern MozambiqueBackgroundMethodsResultsConclusion. BMJ Global Health [Internet]. 2019;4(Suppl 5):e000894. http://gh.bmj.com/lookup/doi/10.1136/bmjgh-2018-000894https://syndication.highwire.org/content/doi/10.1136/bmjgh-2018-000894
(1.77 MB)
. 
Interactions between the Physical and Social Environments with Adverse Pregnancy Events Related to Placental Disorders—A Scoping Review. International Journal of Environmental Research and Public Health [Internet]. 2020;17(15):5421. https://www.mdpi.com/1660-4601/17/15/5421https://www.mdpi.com/1660-4601/17/15/5421/pdf
(1.59 MB)
. 
Investigating placental disorders of pregnancy in sub-Saharan Africa: addressing the gap in a neglected area of research. 2020;17(1):53.
(402.49 KB)
. 
Random urine albumin:creatinine ratio in high-risk pregnancy - Is it clinically useful?. Pregnancy Hypertens. 2013;3(2):112-4.
(189.28 KB)
. 
Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres. J Obstet Gynaecol Can. 2015;37(11):975-87.
(362.1 KB)
. 
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada. Implement Sci. 2018;13(1):8.
(1.89 MB)
. 
Unexpected random urinary protein:creatinine ratio results-limitations of the pyrocatechol violet-dye method. BMC Pregnancy Childbirth. 2013;13:152.
(834.74 KB)
. 